Absci's management, including CFO and CBO Zach Jonasson, CAO Todd Bedrick, and VP of Finance and Investor Relations Alexander Khan, underscored the company's success in forging partnerships across the ...

We recently published a list of Complete List of All AI Companies Under $2 Billion Market Cap. In this article, we are going to take a look at where Absci (NASDAQ:ABSI) stands against other AI ...

Across the recent three months, 7 analysts have shared their insights on Absci ABSI, expressing a variety of opinions spanning from bullish to bearish. In the table below, you'll find a summary of ...

Guggenheim has recently initiated Absci Corp (ABSI) stock to Buy rating, as announced on October 2, 2024, according to Finviz. Earlier, on July 3, 2024, Morgan Stanley had initiated the stock to ...

Absci recently received a $20 million PIPE investment from AMD that improves its runway and R&D platform with AI. ABS-101 appears to be ABSI’s main drug candidate for IBD. However, ABS-201 for ...

Zachariah Branch should quickly emerge as one of the most impactful players on Georgia's football team, showcasing a combination of elite skills that make him a nightmare for opposing defenses ...

https://www.tipranks.com/news/the-fly/dentsply-sirona-to-reposition-byte-business-within-aligner-portfolio Absci (ABSI) and Owkin announced a partnership bringing ...

Collaboration combines Owkin’s novel AI target discovery and agentic AI expertise with Absci’s leading AI de novo design models to accelerate the discovery and design of potential first-in-class ...

VANCOUVER, Wash. and PARIS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to unlock ...